Skip to content
TrustList
Korify Capital AG logo
Venture capital firm

Korify Capital AG

Korify Capital AG

Write a review
Visit WebsiteGet introducedWrite a Review
Own this listing? Claim it
Korify Capital AG cover

About Korify Capital AG

Cambrian is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan – the period of life spent in good health

Refoxy is developing therapeutic medicines intended to treat age-related diseases and improve healthy longevity by focusing on FOXO modulators

This has just been a glimpse of our portfolio Click below to discover more

Alto Neuroscience Wins 2022 BioTech Breakthrough and BioSpace’s 2023 Best Places to Work Awards

Press Release: James Peyer Named 2022 “BioTech Company CEO of the Year” By BioTech Breakthrough

Alto Neuroscience Announces $35 Million Series B Financing

Second Rejuveron Company Transitions into Clinical Stage

GET INVOLVED

FOR FURTHER INFORMATION.

Categories & features

Ask TrustList to introduce you to Korify Capital AG

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Korify Capital AG

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Korify Capital AG.

Korify Capital AG alternatives

Similar listings buyers compare against this one.

Compare side by side
Keep exploring

More on TrustList

Everything here links back to the same verified catalogue. Pick your next stop.